Analysis of the Reasons for DMARD Therapy Discontinuation in Patients with Rheumatoid Arthritis in the Czech and Slovak Republics

A Trial of Etanercept, a Recombinant Tumor Necrosis Factor Receptor:Fc Fusion Protein, in Patients with Rheumatoid Arthritis Receiving Methotrexate

Michael E. Weinblatt, Joel M. Kremer, Arthur D. Bankhurst et al. · New England Journal of Medicine · 1999 · 2.1K citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist

Barry Bresnihan, Jos� Maria Alvaro-Gracia, Mark Cobby et al. · Arthritis & Rheumatism · 1998 · 974 citations

Medicine, Immunology, Pharmacotherapy +16

Termination of slow acting antirheumatic therapy in rheumatoid arthritis: a 14 year prospective evaluation of 1017 consecutive starts

Frederick Wolfe, Donna Hawley, M A Cathey · 2001 · 289 citations

Medicine, Pharmacology, Pharmacotherapy +14

Radiographic outcome of recent-onset rheumatoid arthritis: A 19-year study of radiographic progression

Frederick Wolfe, John T. Sharp · Arthritis & Rheumatism · 1998 · 278 citations

Medicine, Clinical Sciences, Internal Medicine +14

Long‐Term Prospective Study of Methotrexate in the Treatment of Rheumatoid Arthritis

Michael E. Weinblatt, Barbara N. Weissman, Donald E. Holdsworth et al. · Arthritis & Rheumatism · 1992 · 229 citations

Medicine, Clinical Sciences, Pharmacotherapy +11